Skip to content

144Accepted Sep 13, 5:04 PM ET

BridgeBio Pharma, Inc. 144

KKR Genetic Disorder L.P.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:04 PM

Sep 13, 2024

Filed

Sep 13, 2024

Documents

1

Size

6.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.